PLX
Protalix BioTherapeutics (PLX)
$16
About Protalix BioTherapeutics (PLX)
Protalix Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development, production, and commercialization of recombinant therapeutic proteins based on plant cell based expression system. Its products include Alidornase alfa, PRX-115 and PRX-11. The company was by Yoseph Shaaltiel in 1993 and is headquartered in Hackensack, NJ.
Details
Daily high
$2.27
Daily low
$2.14
Price at open
$2.21
52 Week High
$3.19
52 Week Low
$1.32
Market cap
178.9M
Dividend yield
0.00%
Volume
723,457
Avg. volume
658,378
P/E ratio
12.11
Protalix BioTherapeutics News
Details
Daily high
$2.27
Daily low
$2.14
Price at open
$2.21
52 Week High
$3.19
52 Week Low
$1.32
Market cap
178.9M
Dividend yield
0.00%
Volume
723,457
Avg. volume
658,378
P/E ratio
12.11